Medications to Support Weight Loss

Information about Liraglutide (Saxenda®), Semaglutide (Wegovy®) and Tirzepatide (Mounjaro®). 

The Scottish Medicines Consortium (SMC) has approved Liraglutide (Saxenda®), Semaglutide (Wegovy®) and Tirzepatide (Mounjaro®) for restricted use in NHS Scotland for weight management. NHS Fife does not yet have a pathway for introducing these medications.  Unfortunately, until a pathway has been agreed, we are unable to accept referrals for Liraglutide (Saxenda®), Semaglutide (Wegovy®) and Tirzepatide (Mounjaro®).